The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra
- PMID: 25698462
- DOI: 10.1016/j.jviromet.2015.01.001
The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra
Abstract
Two commercial HPV tests target the same 65 bp fragment of the human papillomavirus genome (designated SPF10): the original HPV SPF10 PCR-DEIA-LiPA25 system, version 1, (LiPA25) and the INNO-LiPA HPV Genotyping Extra (INNO-LiPA). The original SPF10 LiPA25 system was designed to have high analytical sensitivity and applied in HPV vaccine and epidemiology studies worldwide. But due to apparent similarities, this test can be easily confused with INNO-LiPA, a more recent assay of which the intended use, i.e., epidemiological or clinical, is currently unclear. The aim was to compare the analytical sensitivity of SPF10 LiPA25 to that of INNO-LiPA on the level of general HPV detection and genotyping. HPV testing by both assays was performed on the same DNA isolated from cervical swab (n = 365) and biopsy (n = 42) specimens. In cervical swabs, SPF10 LiPA25 and INNO-LiPA identified 35.3% and 29.3% multiple infections, 52.6% and 51.5% single infections, and no HPV type in 12.1% and 19.2%, respectively. Genotyping results were 64.7% identical, 26.0% compatible and 9.3% discordant between both methods. SPF10 LiPA25 detected significantly more genotypes (p < 0.001). The higher analytical sensitivity of SPF10 LiPA25 was confirmed by the MPTS123 genotyping assay. HPV positivity by the general probes in SPF10 DEIA was significantly higher (87.9%) than by those on INNO-LiPA (77.0%) (kappa = 0.592, p < 0.001). In cervical biopsies, SPF10 LiPA25 and INNO-LiPA identified 21.4% and 9.5% multiple types, 76.2% and 81.0% single types, and no type in 2.4% and 9.5%, respectively. Between both tests, the identification of genotypes was 76.3% identical, 14.3% compatible and 9.5% discordant. Overall, significantly more genotypes were detected by SPF10 LiPA25 (kappa = 0.853, p = 0.022). HPV positivity was higher by the SPF10 DEIA (97.6%) than by the INNO-LiPA strip (92.9%). These results demonstrate that SPF10 LiPA25 is more suitable for HPV genotyping in epidemiologic and vaccine-related studies, due to its higher analytical sensitivity.
Keywords: Epidemiology; Genotyping; Human papillomavirus; INNO-LiPA; LiPA(25); SPF(10).
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.J Clin Virol. 2012 Nov;55(3):256-61. doi: 10.1016/j.jcv.2012.07.013. Epub 2012 Aug 9. J Clin Virol. 2012. PMID: 22877561
-
Comparison of SPF10 real-time PCR and conventional PCR in combination with the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus in cervical samples.J Virol Methods. 2013 Dec;194(1-2):113-7. doi: 10.1016/j.jviromet.2013.08.013. Epub 2013 Aug 23. J Virol Methods. 2013. PMID: 23978605
-
Evaluation of an automated SPF10-LiPA25 assay for detection and typing of human papillomavirus in archival samples.J Virol Methods. 2014 Apr;199:116-8. doi: 10.1016/j.jviromet.2014.01.012. Epub 2014 Jan 30. J Virol Methods. 2014. PMID: 24487100
-
[Current problems and recent advances in the molecular diagnosis of genital human papillomavirus infections].Mikrobiyol Bul. 2014 Oct;48(4):689-706. doi: 10.5578/mb.7631. Mikrobiyol Bul. 2014. PMID: 25492665 Review. Turkish.
-
Relationship of human papillomavirus with seborrheic keratosis of the female genital tract - a case-series and literature review.Histol Histopathol. 2021 Dec;36(12):1209-1218. doi: 10.14670/HH-18-357. Epub 2021 May 25. Histol Histopathol. 2021. PMID: 34170001 Review.
Cited by
-
Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma.JAMA Otolaryngol Head Neck Surg. 2019 May 1;145(5):460-466. doi: 10.1001/jamaoto.2019.0119. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 30920604 Free PMC article.
-
Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF10-DEIA-LiPA25 (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates.J Clin Microbiol. 2020 Oct 21;58(11):e01626-20. doi: 10.1128/JCM.01626-20. Print 2020 Oct 21. J Clin Microbiol. 2020. PMID: 32907991 Free PMC article.
-
High prevalence of HPV16 and high-grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.Acta Obstet Gynecol Scand. 2023 Sep;102(9):1227-1235. doi: 10.1111/aogs.14627. Epub 2023 Jul 19. Acta Obstet Gynecol Scand. 2023. PMID: 37469102 Free PMC article.
-
Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study.EClinicalMedicine. 2025 Jan 15;79:103018. doi: 10.1016/j.eclinm.2024.103018. eCollection 2025 Jan. EClinicalMedicine. 2025. PMID: 39896062 Free PMC article.
-
Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.Papillomavirus Res. 2019 Jun;7:26-42. doi: 10.1016/j.pvr.2018.12.002. Epub 2018 Dec 30. Papillomavirus Res. 2019. PMID: 30599280 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources